Moody Aldrich Partners’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-615
Closed -$200K 248
2024
Q1
$200K Buy
+615
New +$151K 0.03% 215
2023
Q3
Sell
-702
Closed -$200K 219
2023
Q2
$200K Sell
702
-19,345
-96% -$5.37M 0.04% 152
2023
Q1
$4.35M Sell
20,047
-738
-4% -$144K 0.88% 47
2022
Q4
$4.27M Buy
20,785
+7,210
+53% +$1.82M 0.87% 51
2022
Q3
$3.77M Sell
13,575
-26,653
-66% -$6.78M 0.78% 59
2022
Q2
$7.69M Buy
40,228
+12,167
+43% +$2.15M 1.51% 17
2022
Q1
$5.82M Buy
+28,061
New +$4.63M 0.82% 50

Other funds holding SWAV

Moody Aldrich Partners's SWAV Position: Q2 2024 in Review

Moody Aldrich Partners sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 615 shares — an estimated $200K sold.

Moody Aldrich Partners first reported a position in SWAV in Q1 2022 and held it in 7 quarters. The position peaked at $7.69M in Q2 2022. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Moody Aldrich Partners reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Moody Aldrich Partners sold 615 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $200K.
  • Moody Aldrich Partners first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2022 and held it in 7 quarters.
  • Moody Aldrich Partners's Shockwave Medical, Inc. Common Stock position peaked at $7.69M in Q2 2022.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Moody Aldrich Partners's 13F filing for Q2 2024, filed 24 Jul 2024.